A Study of BMS-986205 Given in Combination With Nivolumab in Patients With Advanced Tumors

NCT03192943 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancer

Interventions

DRUG: BMS-986205
BIOLOGICAL: Nivolumab

Sponsor

Bristol-Myers Squibb